Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 45 results.
User Information
Export Records
  1. 1.   Temporal analysis of mRNA expression profiles in Orientia infected C3HeB/FeJ mouse
  2. Chao, Chien-Chung; Yang, Ruoting; Zhang, Zhiwen; Belinskaya, Tatyana; Chan, Chye-Teik; Miller, Stacy-Ann; Hammamieh, Rasha; Jett, Marti; Ching, Wei-Mei
  3. BMC microbiology. 2020, Jan 06; 20(1): 3.
  1. 2.   GWASdb: a database for human genetic variants identified by genome-wide association studies
  2. Li, M. L. J.; Wang, P. W.; Liu, X. R.; Lim, E. L.; Wang, Z. Y.; Yeager, M.; Wong, M. P.; Sham, P. C.; Chanock, S. J.; Wang, J. W.
  3. Nucleic Acids Research. 2012, Jan; 40(D1): D1047-D1054.
  1. 3.   N-Hydroxyethyl-4-aza-didehydropodophyllotoxin derivatives as potential antitumor agents
  2. Kumar, A.; Kumar, V.; Alegria, A. E.; Malhotra, S. V.
  3. European Journal of Pharmaceutical Sciences. 2011, Sep; 44(1-2): 21-26.
  1. 4.   Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection
  2. Kim, H. K.; Kim, J.; Korolevich, S.; Choi, I. J.; Kim, C. H.; Munroe, D. J.; Green, J. E.
  3. Bmc Medical Genomics. 2011, Jun; 4: 11.
  1. 5.   Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale
  2. Stumpel, D.; Schotte, D.; Lange-Turenhout, E. A. M.; Schneider, P.; Seslija, L.; de Menezes, R. X.; Marquez, V. E.; Pieters, R.; den Boer, M. L.; Stam, R. W.
  3. Leukemia. 2011, Mar; 25(3): 429-439.
  1. 6.   CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
  2. Katsounas, A.; Schlaak, J. F.; Lempicki, R. A.
  3. International Reviews of Immunology. 2011, Oct-Dec; 30(5-6): 366-378.
  1. 7.   Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency
  2. Pemov, A.; Park, C.; Reilly, K. M.; Stewart, D. R.
  3. Bmc Genomics. 2010, Mar; 11: 16.
  1. 8.   DNA fingerprinting of the NCI-60 cell line panel
  2. Lorenzi, P. L.; Reinhold, W. C.; Varma, S.; Hutchinson, A. A.; Pommier, Y.; Chanock, S. J.; Weinstein, J. N.
  3. Molecular Cancer Therapeutics. 2009 8(4): 713-724.
  1. 9.   Seeking unique and common biological themes in multiple gene lists or datasets: pathway pattern extraction pipeline for pathway-level comparative analysis
  2. Yi, M.; Mudunuri, U.; Che, A.; Stephens, R. M.
  3. Bmc Bioinformatics. 2009 10 AR 200: 1-17.
  1. 10.   Whole chromosome alterations predict survival in high-risk neuroblastoma without MYCN amplification
  2. Bilke, S.; Chen, Q. R.; Wei, J. S.; Khan, J.
  3. Clinical Cancer Research. 2008 14(17): 5540-5547.
  1. 11.   An integrated cross-platform prognosis study on neuroblastoma patients
  2. Chen, Q. R.; Song, Y. K.; Wei, J. S.; Bilke, S.; Asgharzadeh, S.; Seeger, R. C.; Khan, J.
  3. Genomics. 2008 92(4): 195-203.
  1. 12.   Connecting chemosensitivity, gene expression and disease
  2. Covell, D. G.
  3. Trends in Pharmacological Sciences. 2008 29(1): 1-5.
  1. 13.   AP-1 a target for cancer prevention
  2. Matthews, C. P.; Colburn, N. H.; Young, M. R.
  3. Current Cancer Drug Targets. 2007, Jun; 7(4): 317-324.
  1. 14.   Fra-1 a target for cancer prevention or intervention
  2. Young, M. R.; Colburn, N. H.
  3. Gene. 2006, Sep; 379: 1-11.
  1. 15.   Identification of molecular markers for endometriosis in blood lymphocytes by using deoxyribonucleic acid microarrays
  2. Flores, I.; Rivera, E.; Mousses, S.; Chen, Y. D.; Rozenblum, E.
  3. Fertility and Sterility. 2006, Jun; 85(6): 1676-1683.
  1. 16.   Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen
  2. Huang, R.; Wallqvist, A.; Covell, D. G.
  3. Genomics. 2006, MAR; 87(3): 315-328.
  1. 17.   Transcriptomic response to differentiation induction
  2. Patton, G. W.; Stephens, R.; Sidorov, I. A.; Xiao, X.; Lempicki, R. A.; Dimitrov, D. S.; Shoemaker, R. H.; Tudor, G.
  3. Bmc Bioinformatics. 2006, FEB 17; 7
  1. 18.   Analysis of mass spectral serum profiles for biomarker selection
  2. Ressom, H. W.; Varghese, R. S.; bdel-Hamid, M.; Eissa, S. A. L.; Saha, D.; Goldman, L.; Petricoin, E. F.; Conrads, T. P.; Veenstra, T. D.; Loffredo, C. A.; Goldman, R.
  3. Bioinformatics. 2005, NOV 1; 21(21): 4039-4045.
  1. 19.   Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies - Distinct HLA-A, -B, -Cw,-DRB1 and -DQA1 allelic profiles and motifs define clinicopothologic groups in Caucasians
  2. O'Hanlon, T. P.; Carrick, D. M.; Arnett, F. C.; Reveille, J. D.; Carrington, M.; Gao, X. J.; Oddis, C. V.; Morel, P. A.; Malley, J. D.; Malley, K.; Dreyfuss, J.; Shamim, E. A.; Rider, L. G.; Chanock, S. J.; Foster, C. B.; Bunch, T.; Plotz, P. H.; Love, L. A.; Miller, F. W.
  3. Medicine. 2005, NOV; 84(6): 338-349.
  1. 20.   Molecular alterations in primary prostate cancer after androgen ablation therapy
  2. Best, C. J. M.; Gillespie, J. W.; Yi, Y. J.; Chandramouli, G. V. R.; Perlmutter, M. A.; Gathright, Y.; Erickson, H. S.; Georgevich, L.; Tangrea, M. A.; Duray, P. H.; Gonzalez, S.; Velasco, A.; Linehan, W. M.; Matusik, R. J.; Price, D. K.; Figg, W. D.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Clinical Cancer Research. 2005, OCT 1; 11(19, Part 1): 6823-6834.
  1. 21.   Retinoic acid-induced downmodulation of telomerase activity in human cancer cells
  2. Xiao, X. D.; Sidorov, I. A.; Gee, J.; Lempicki, R. A.; Dimitrov, D. S.
  3. Experimental and Molecular Pathology. 2005, OCT; 79(2): 108-117.
  1. 22.   Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
  2. Zorn, K. K.; Bonome, T.; Gangi, L.; Chandramouli, G. V. R.; Awtrey, C. S.; Gardner, G. J.; Barrett, J. C.; Boyd, J.; Birrer, M. J.
  3. Clinical Cancer Research. 2005, SEP 15; 11(18): 6422-6430.
  1. 23.   Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
  2. Ryan, Q. C.; Headlee, D.; Acharya, M.; Sparreboom, A.; Trepel, J. B.; Ye, J.; Figg, W. D.; Hwang, K.; Chung, E. J.; Murgo, A.; Melillo, G.; Elsayed, Y.; Monga, M.; Kalnitskiy, M.; Zwiebel, J.; Sausville, E. A.
  3. Journal of Clinical Oncology. 2005, JUN 10; 23(17): 3912-3922.
  1. 24.   Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma
  2. Brouwers, F. M.; Petricoin, E. F.; Ksinantova, L.; Breza, J.; Rajapakse, V.; Ross, S.; Johann, D.; Mannelli, M.; Shulkin, B. L.; Kvetnansky, R.; Eisenhofer, G.; Walther, M. M.; Hitt, B. A.; Conrads, T. P.; Veenstra, T. D.; Mannion, D. P.; Wall, M. R.; Wolfe, G. M.; Fusaro, V. A.; Liotta, L. A.; Pacak, K.
  3. Endocrine-Related Cancer. 2005, JUN; 12(2): 263-272.
  1. 25.   Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A
  2. Witvrouw, M.; Fikkert, V.; Hantson, A.; Pannecouque, C.; O'Keefe, B. R.; McMahon, J.; Stamatatos, L.; De Clercq, E.; Bolmstedt, A.
  3. Journal of Virology. 2005, JUN; 79(12): 7777-7784.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel